Abstract
No public abstract is available from the verified source records.
Asma Vafadar
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
ror
Confidence 99%
ror
Confidence 99%
openalex
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Oligodendrocytes Do Not Export NAA-Derived Aspartate In Vitro
10.1007/s11064-016-1985-y · 2017
Gene and Cellular Therapies for Leukodystrophies
10.3390/pharmaceutics15112522 · 2023
Long-Term Functional Outcomes after Hematopoietic Stem Cell Transplant for Early Infantile Krabbe Disease
10.1016/j.bbmt.2018.06.020 · 2018
An update on clinical, pathological, diagnostic, and therapeutic perspectives of childhood leukodystrophies
10.1080/14737175.2020.1699060 · 2020
Gene therapy for leukodystrophy: progress, challenges and opportunities
10.1517/21678707.2016.1151352 · 2016
Encapsulated cells as an enzyme replacement therapy for metachromatic leukodystrophy
10.1016/j.jconrel.2025.114307 · 2025
Dose-response evaluation of intravenous gene therapy in a symptomatic mouse model of metachromatic leukodystrophy
10.1016/j.omtm.2024.101248 · 2024
Distinct patterns of complex rearrangements and a mutational signature of microhomeology are frequently observed in PLP1 copy number gain structural variants
10.1186/s13073-019-0676-0 · 2019
The arylsulphatase A gene and molecular genetics of metachromatic leucodystrophy
10.1136/jmg.31.9.663 · 1994
Transduced CD34+ cells from adrenoleukodystrophy patients with HIV-derived vector mediate long-term engraftment of NOD/SCID mice
10.1016/s1525-0016(03)00002-9 · 2003
Current and future pharmacological treatment strategies in X-linked adrenoleukodystrophy
10.1111/j.1750-3639.2010.00393.x · 2010
Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy
10.1126/science.1233158 · 2013
Unresolved referenced work
2026
Leukodystrophies in Children: diagnosis, Care, and Treatment
10.1542/peds.2021-053126 · 2021
The burden of inherited leukodystrophies in children
10.1212/wnl.0b013e3181eee46b · 2010
Krabbe disease successfully treated via monotherapy of intrathecal gene therapy
10.1172/jci133953 · 2020
Combination HSCT and intravenous AAV-mediated gene therapy in a canine model proves pivotal for translation of Krabbe disease therapy
10.1016/j.ymthe.2023.11.014 · 2024
Krabbe disease: new hope for an old disease
10.1016/j.neulet.2021.135841 · 2021
Safety of intrathecal delivery of recombinant human arylsulfatase A in children with metachromatic leukodystrophy: results from a phase 1/2 clinical trial
10.1016/j.ymgme.2020.07.002 · 2020
CRISPR-dependent base editing as a therapeutic strategy for rare monogenic disorders
10.3389/fgeed.2025.1553590 · 2025
Lentiviral hematopoietic cell gene therapy for X-linked adrenoleukodystrophy
10.1016/b978-0-12-386509-0.00010-7 · 2012
Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy
10.1126/science.1171242 · 2009
Mutation Update of ARSA and PSAP Genes Causing Metachromatic Leukodystrophy
10.1002/humu.22919 · 2016
A systematic review on the birth prevalence of metachromatic leukodystrophy
10.1186/s13023-024-03044-w · 2024
Stem cell derived oligodendrocytes to study myelin diseases
10.1002/glia.23733 · 2020
Hypomyelinating leukodystrophies - a molecular insight into the white matter pathology
10.1111/cge.12811 · 2016
Cloning and expression of cDNA encoding human galactocerebrosidase, the enzyme deficient in globoid cell leukodystrophy
10.1093/hmg/2.11.1841 · 1993
RNA therapeutics: rNAi and antisense mechanisms and clinical applications
10.14304/surya.jpr.v4n7.5 · 2016
A new familial infantile form of diffuse brain-sclerosis
10.1093/brain/awt232 · 2013
POLR3-related leukodystrophy: how do mutations affecting RNA polymerase III subunits cause hypomyelination?
10.12703/r/10-12 · 2021
Mutations in POLR3A and POLR3B are a major cause of hypomyelinating leukodystrophies with or without dental abnormalities and/or hypogonadotropic hypogonadism
10.1136/jmedgenet-2012-101357 · 2013
D-Aspartate treatment attenuates myelin damage and stimulates myelin repair
10.15252/emmm.201809278 · 2019
Lysosomal arylsulfatase deficiencies in humans: chromosome assignments for arylsulfatase A and B
10.1073/pnas.76.4.1957 · 1979
Mutation in POLR3K causes hypomyelinating leukodystrophy and abnormal ribosomal RNA regulation
10.1212/nxg.0000000000000289 · 2018
The neurobiology of X-linked adrenoleukodystrophy, a demyelinating peroxisomal disorder
10.1016/s0166-2236(98)01319-8 · 1999
Hematopoietic Stem Cell Transplantation in CSF1R-Related Leukoencephalopathy: retrospective Study on Predictors of Outcomes
10.3390/pharmaceutics14122778 · 2022
Hematologic Cancer after Gene Therapy for Cerebral Adrenoleukodystrophy
10.1056/nejmoa2405541 · 2024
Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy
10.1056/nejmoa1700554 · 2017
Lentiviral Gene Therapy for Cerebral Adrenoleukodystrophy
10.1056/nejmoa2400442 · 2024
Initial Biomarker and Clinical Findings from the CANaspire Canavan Disease Gene Therapy Trial: Exploration of Connections between NAA and Disease Severity
2023
Advances in AAV-mediated gene replacement therapy for pediatric monogenic neurological disorders
10.1016/j.omtm.2024.101357 · doi-reference
Mechanistic advances in factors influencing phenotypic variability in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: a review
10.3389/fneur.2025.1573052 · doi-reference
The impact of leukodystrophies on parents’ lives
10.1093/jpepsy/jsaf072 · doi-reference
Overlapping Protein Accumulation Profiles of CADASIL and CAA: is There a Common Mechanism Driving Cerebral Small-Vessel Disease?
10.1016/j.ajpath.2020.11.015 · doi-reference
Treatment of leukodystrophies: advances and challenges
10.1016/j.ejpn.2025.03.016 · doi-reference
Metachromatic leukodystrophy and transplantation: remyelination, no cross-correction
10.1002/acn3.50975 · doi-reference
Pubertal outcomes of children transplanted with allogeneic stem cells after myeloablative total body irradiation or busulfan: influence of age and sex is confirmed, while a role of chronic graft-versus-host disease in delayed puberty onset is revealed
10.1111/petr.13773 · doi-reference
Leukodystrophies
10.1212/con.0000000000000560 · doi-reference
Case definition and classification of leukodystrophies and leukoencephalopathies
10.1016/j.ymgme.2015.01.006 · doi-reference
Relative incidence of inherited white matter disorders in childhood to acquired pediatric demyelinating disorders
10.1016/j.spen.2012.10.001 · doi-reference
Improvement of white matter changes on neuroimaging modalities after stem cell transplant in metachromatic leukodystrophy
10.1001/jamaneurol.2013.629 · doi-reference
Diagnosis, prognosis, and treatment of leukodystrophies
10.1016/s1474-4422(19)30143-7 · doi-reference
Vanishing white matter disease
10.1016/s1474-4422(06)70440-9 · doi-reference
Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter
10.1002/ana.10112 · doi-reference
Leukodystrophies: a proposed classification system based on pathological changes and pathogenetic mechanisms
10.1007/s00401-017-1739-1 · doi-reference
Microbiota gut-brain axis: implications for pediatric-onset leukodystrophies
10.3389/fnut.2024.1417981 · doi-reference
Recessive mutations in POLR1C cause a leukodystrophy by impairing biogenesis of RNA polymerase III
10.1038/ncomms8623 · doi-reference
New therapeutic approaches for Krabbe disease: the potential of pharmacological chaperones
10.1002/jnr.23762 · doi-reference
Alexander disease: an astrocytopathy that produces a leukodystrophy
10.1111/bpa.12601 · doi-reference
Metachromatic Leukodystrophy: diagnosis, Modeling, and Treatment Approaches
10.3389/fmed.2020.576221 · doi-reference
Hematopoietic stem cell transplantation in leukodystrophies
10.1016/b978-0-323-99209-1.00017-x · doi-reference
Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial
10.1016/s0140-6736(16)30374-9 · doi-reference
Elivaldogene autotemcel approved for treatment of cerebral adrenoleukodystrophy (CALD) in males: A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG)
10.1016/j.gimo.2023.100835 · doi-reference
Mendelian adult-onset leukodystrophy genes in Alzheimer’s disease: critical influence of CSF1R and NOTCH3
10.1016/j.neurobiolaging.2018.01.015 · doi-reference
Leukodystrophies and genetic leukoencephalopathies in children
10.1016/j.neurol.2019.04.003 · doi-reference
Addressing the Value of Gene Therapy and Enhancing Patient Access to Transformative Treatments
10.1016/j.ymthe.2018.10.017 · doi-reference
Safety of Direct Intraparenchymal AAVrh.10-Mediated Central Nervous System Gene Therapy for Metachromatic Leukodystrophy
10.1089/hum.2020.269 · doi-reference
Allogeneic hematopoietic cell transplantation for adult metachromatic leukodystrophy: a case series
10.1182/bloodadvances.2023011836 · doi-reference
10.1101/2025.03.12.642609
10.1101/2025.03.12.642609 · doi-reference
Conditions for combining gene therapy with bone marrow transplantation in murine Krabbe disease
10.34172/bi.2020.13 · doi-reference
Characterization of a novel adeno-associated viral vector with preferential oligodendrocyte tropism
10.1038/gt.2016.62 · doi-reference
The Challenge of Gene Therapy for Neurological Diseases: strategies and Tools to Achieve Efficient Delivery to the Central Nervous System
10.1089/hum.2020.105 · doi-reference
Leukodystrophies
10.1007/978-1-4614-0653-2_13 · doi-reference
A clinical approach to the diagnosis of patients with leukodystrophies and genetic leukoencephelopathies
10.1016/j.ymgme.2014.12.434 · doi-reference
Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia: review of Clinical Manifestations as Foundations for Therapeutic Development
10.3389/fneur.2021.788168 · doi-reference
Neurogenetics of Pelizaeus-Merzbacher disease
10.1016/b978-0-444-64076-5.00045-4 · doi-reference
Emerging cellular themes in leukodystrophies
10.3389/fcell.2022.902261 · doi-reference
The landscape of pediatric genetic white matter disorders at a tertiary referral hospital in Upper Egypt and the report of 31 novel variants
10.1186/s13052-025-02031-6 · doi-reference
10.1016/j.bbmt.2011.09.013
10.1016/j.bbmt.2011.09.013 · doi-reference
Adult-onset leukodystrophies: a practical guide, recent treatment updates, and future directions
10.3389/fneur.2023.1219324 · doi-reference